Home » Topics » BioWorld Science

BioWorld Science
RSS

Alaunos and NCI extend CRADA to assess use of Sleeping Beauty technology for TCR T-cell therapy

June 30, 2022

Novel mouse models of BrafV600E-driven thyroid tumors

June 30, 2022

Palacky University patents new terpenoid derivatives

June 30, 2022

Reistone Biopharma divulges new CatC inhibitors

June 30, 2022

Roche presents new EGFR mutant inhibitors

June 30, 2022

Eubulus Biotherapeutics discloses new GPX4 inhibitors

June 30, 2022

Sunshine Lake Pharma patents new GCGR and/or GLP-1 receptor agonists

June 30, 2022

ADAM10 may be a promising therapeutic target for AML

June 30, 2022

Myelin-forming cells change in multiple brain diseases

June 29, 2022

Scorpion selects Exon 20 mutant EGFR inhibitor STX-721 as development candidate

June 29, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...